Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials
Although their underlying mechanisms differ, finerenone reduces albuminuria to the same extent as SGLT-2 inhibitors, said George Bakris, MD, professor of medicine and director of the American Heart Association Comprehensive Hypertension Center at the University of Chicago Medicine.
Watch video Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials online without registration, duration hours minute second in high quality. This video was added by user AJMCtv 27 October 2020, don't forget to share it with your friends and acquaintances, it has been viewed on our site 3,131 once and liked it 31 people.